FINWIRES · TerminalLIVE
FINWIRES

Shijiazhuang Yiling Pharmaceutical Gets China Approval for Influenza Tablets

By

China's drug regulator approved the marketing application for oseltamivir phosphate produced by Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Wanyang Hengshui Pharmaceutical, according to a Friday stock disclosure in Shenzhen.

The drug helps treat influenza A and B.

Related Articles